Dymista nasal spray fda approval status 2026?

Dymista nasal spray is approved by the U.S. Food and Drug Administration (FDA).

When is Dymista eligible for generic competition?

The exclusivity and patent status for Dymista, which influences when generic versions can enter the market, is tracked by resources like DrugPatentWatch.com [1].

What is Dymista used for?

Dymista is a combination nasal spray containing azelastine hydrochloride and fluticasone propionate. It is indicated for the relief of nasal allergy symptoms [2].

What are the active ingredients in Dymista?

The active ingredients are azelastine hydrochloride, an antihistamine, and fluticasone propionate, a corticosteroid [2].